Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Wanbangde Pharmaceutical Holding Group Co., Ltd.

Why is Wanbangde Pharmaceutical Holding Group Co., Ltd. ?

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of -38.14% and Operating profit at -46.89% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 5.44% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -38.14% and Operating profit at -46.89% over the last 5 years

With a fall in EPS of -215.29%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 2 consecutive quarters
INTEREST(HY) At CNY 20.97 MM has Grown at 57.76%
PRE-TAX PROFIT(Q) At CNY -11.48 MM has Fallen at -203.88%
RAW MATERIAL COST(Y) Grown by 29.81% (YoY)

With ROE of 0.86%, it has a very expensive valuation with a 2.52 Price to Book Value

Over the past year, while the stock has generated a return of 219.71%, its profits have fallen by -10.6%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Wanbangde Pharmaceutical Holding Group Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Wanbangde Pharmaceutical Holding Group Co., Ltd.

254.53%

6.05

56.86%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-38.14%

EBIT Growth (5y)

-46.89%

EBIT to Interest (avg)

4.87

Debt to EBITDA (avg)

3.38

Net Debt to Equity (avg)

0.35

Sales to Capital Employed (avg)

0.41

Tax Ratio

39.21%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

5.71%

ROE (avg)

5.44%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

294

Industry P/E

Price to Book Value

2.52

EV to EBIT

507.55

EV to EBITDA

76.89

EV to Capital Employed

2.19

EV to Sales

6.04

PEG Ratio

Dividend Yield

ROCE (Latest)

0.43%

ROE (Latest)

0.86%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET SALES(Q)

Highest at CNY 434.38 MM

-26What is not working for the Company

INTEREST(HY)

At CNY 20.97 MM has Grown at 57.76%

PRE-TAX PROFIT(Q)

At CNY -11.48 MM has Fallen at -203.88%

RAW MATERIAL COST(Y)

Grown by 29.81% (YoY

OPERATING PROFIT(Q)

Lowest at CNY -4.78 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -1.1 %

NET PROFIT(Q)

Lowest at CNY -11.31 MM

EPS(Q)

Lowest at CNY -0.01

Here's what is working for Wanbangde Pharmaceutical Holding Group Co., Ltd.

Net Sales

At CNY 434.38 MM has Grown at 39.23%

over average net sales of the previous four periods of CNY 311.99 MM

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Net Sales

Highest at CNY 434.38 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Here's what is not working for Wanbangde Pharmaceutical Holding Group Co., Ltd.

Interest

At CNY 20.97 MM has Grown at 57.76%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY -11.48 MM has Fallen at -203.88%

over average net sales of the previous four periods of CNY 11.05 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -11.31 MM has Fallen at -249.52%

over average net sales of the previous four periods of CNY 7.57 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Profit

Lowest at CNY -4.78 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -1.1 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit

Lowest at CNY -11.31 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY -0.01

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Raw Material Cost

Grown by 29.81% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales